Drug Profile
Magnesium valproate
Alternative Names: MagneValLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator BioLink Life Sciences
- Class Antiepileptic drugs
- Mechanism of Action GABA uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Bipolar disorders; Epilepsy
Highest Development Phases
- No development reported Bipolar disorders; Epilepsy
Most Recent Events
- 28 Jan 2019 No recent reports of development identified for clinical-Phase-Unknown development in Bipolar-disorders in USA (PO)
- 28 Jan 2019 No recent reports of development identified for clinical-Phase-Unknown development in Epilepsy in USA (PO)
- 12 Aug 2016 Chemical structure information added